Abstract
Toy et al . described 17 infants (33 eyes) who were treated with intravitreal bevacizumab (0.625 mg) injection for type 1 retinopathy of prematurity (ROP) followed by subsequent exam under anesthesia and fluorescein angiography (FA) taken after 50 weeks of gestational age (1). All eyes had a “scalloped regression” pattern of the peripheral retina on FA. Recurrence or chronic vascular arrest based on FA findings were noted in 30 eyes (91%) for which secondary laser was added to areas of persistent non-perfusion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
